Cirrhotic patients at increased risk of peptic ulcer bleeding: A nationwide population-based cohort study

Alimentary Pharmacology and Therapeutics

Volumn 36, Issue 6, 2012, Pages 542-550

  Luo, J C ^a,b   Leu, H B ^a,b   Hou, M C ^a,b   Huang, C C ^a,b   Lin, H C ^a,b   Lee, F Y ^a,b   Chang, F Y ^a,b   Chan, W L ^a,b   Lin, S J ^a,b   Chen, J W ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; TICLOPIDINE; WARFARIN;

ADULT; AGE; ANAMNESIS; ARTICLE; CHRONIC HEPATITIS; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; FEMALE; HEALTH CARE COST; HUMAN; HYPERTENSION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; PEPTIC ULCER BLEEDING; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SOCIOECONOMICS; TAIWAN; URBAN RURAL DIFFERENCE; VARICOSIS;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TAIWAN;

EID: 84865449179     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05225.x     Document Type: Article

References (30)

1. Hou MC, Lin HC, Liu TT, et al,. Antibiotics prophylaxis after endoscopic therapy prevents re-bleeding in acute variceal hemorrhage. Hepatology 2004; 39: 746-53.
2. Sacchetti C, Capello M, Rebecchi P, et al,. Frequency of upper gastrointestinal lesions in patients with liver cirrhosis. Dig Dis Sci 1988; 33: 1218-22.
3. Rabinovitz M, Yoo YK, Schade RR, et al,. Prevalence of endoscopic findings in 510 consecutive individuals with cirrhosis evaluated prospectively. Dig Dis Sci 1990; 35: 705-10. (Pubitemid 20207372)
4. Chen LS, Lin HC, Hwang SJ, Lee FY, Hou MC, Lee SD,. Prevalence of gastric ulcer in cirrhotic patients and its relations to portal hypertension. J Gastroenterol Hepatol 1996; 11: 59-64.
5. Siringo S, Burroughs AK, Bolondi L, et al,. Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol 1995; 22: 633-41.
6. Kamalaporn P, Sobhonslidsuk A, Jatchavala J, Atisook K, Rattanasiri S, Pramoolsinsap C,. Factors predisposing to peptic ulcer disease in asymptomatic cirrhotic patients. Aliment Pharmacol Ther 2005; 21: 1459-65. (Pubitemid 40874163)
7. Luo JC, Hwang SJ, Wu JC, et al,. Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan. Cancer 1999; 86: 799-804. (Pubitemid 29399919)
8. Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC,. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc 2007; 106: 148-55.
9. Bureau of National Health Insurance. 2001 National Health Insurance Annual Statistical Report. Taipei, Taiwan: Bureau of National Health Insurance, 2002.
10. Luo JC, Leu HB, Huang KW, et al,. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ 2011; 183: E1345-51.
11. Huang KW, Luo JC, Leu HB, et al,. Chronic obstructive pulmonary disease: an independent risk factor for peptic ulcer bleeding: a nationwide population-based study. Aliment Pharmacol Ther 2012; 35: 796-802.
12. Pearl J,. Understanding propensity scores. In:, Pearl J, ed. Causality: Models, Reasoning, and Inference, 2nd edn. Cambridge, UK: Cambridge University press, 2009; 348-51.
13. Chiu CC, Huang CC, Chan WL, et al,. Increased risk of ischemic stroke in patients with systemic lupus erythematosus: a nationwide population-based study. Intern Med 2012; 51: 17-21.
14. WHO Collaborating Center for Drug Statistics Methodology. ATC Index With DDDs 2003. Oslo: WHO, 2003.
15. Lo GH, Yu HC, Chan YC, et al,. The effect of eradication of Helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis. Gastrointest Endosc 2005; 62: 350-6.
16. Huang JQ, Sridhar S, Hunt RH,. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002; 359: 14-22. (Pubitemid 34119190)
17. Hsiang KW, Chen TS, Lin HY, et al,. Incidence and possible risk factors for clinical upper GI events in patients administrating selective cyclooxygenase-2 inhibitors: a prospective, observational, cohort study in Taiwan. Clin Ther 2010; 32: 1294-303.
18. Sugimoto M, Sakai K, Kita M, Imanishi J, Yamaoka Y,. Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int 2009; 75: 96-103.
19. Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB, Lin JT,. Early Helicobacter pylori eradication decreases the risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology 2009; 137: 1641-8.
20. Howden C,. Helicobacter pylori-related peptic ulcer disease: causation, diagnosis, treatment, and complications. In:, Irvine E, Hunt R, eds. Evidence-Based Gastroenterology. Hamilton (Ontario): BC Decker, 2002; 79-101.
21. Siringo S, Vaira D, Menegatti M, et al,. High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci 1997; 42: 2024-30. (Pubitemid 27501984)
22. Chen JJ, Changchien CS, Tai DI, Chiou SS, Lee CM, Kuo CH,. Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study. Dig Dis Sci 1994; 39: 1565-8.
23. Iwao T, Toyonaga A, Ikegami M, et al,. Gastric mucous generation in cirrhotic patients with portal hypertension. Effects of tetraprenylacetone. Dig Dis Sci 1996; 41: 1727-32. (Pubitemid 26319746)
24. McCormack TT, Sims J, Eyre-Brook I, et al,. Gastric lesion in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut 1985; 26: 1226-32. (Pubitemid 16216270)
25. Kameyama J, Suzuki Y, Suzuki A, et al,. Gastric mucus secretion in portal hypertension. J Gastroenterol Hepatol 1989; 4 (Suppl. 1): 126-8. (Pubitemid 20007372)
26. Sarfeh IJ, Soliman H, Waxman K, et al,. Impaired oxygenation of gastric mucosa in portal hypertension. The basis for increased susceptibility to injury. Dig Dis Sci 1989; 34: 225-8. (Pubitemid 19068172)
27. Beck PL, McKnight W, Lee SS, Wallace JL,. Prostaglandin modulation of the gastric vasculature and mucosal integrity in cirrhotic rats. Am J Physiol 1993; 265: G453-8. (Pubitemid 23298280)
28. Afessa B, Kubilis PS,. Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction. Am J Gastroenterol 2000; 95: 484-9. (Pubitemid 30106181)
29. Rudler M, Rousseau G, Benosman H, et al,. Peptic ulcer bleeding in patients with or without cirrhosis: different diseases but the same prognosis? Aliment Pharmacol Ther 2012; 36: 166-72.
30. Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ, Lin JT,. Long-term peptic ulcer rebleeding risk estimation in patients undergoing haemodialysis: a 10-year nationwide cohort study. Gut 2011; 60: 1038-42.